STADA Romania, the Romanian subsidiary of STADA Arzneimittel AG, is starting construction work on the first pharmaceuticals factory to be built by an international company in Romania in the last 30 years. With an investment of more than 50 million euros, this new production facility is located in the Arieș Industrial Park in Turda, Cluj county. The greenfield project is partly supported in its implementation by the Romanian Government through a state aid contribution.
The new production and packaging unit will initially comprise 9 state-of-the-art technological lines for solid dosage products (capsules and tablets), with a capacity of 120 million boxes of pharmaceutical product per year. The total surface area of the unit is approximately 30,000 sqm and allows for a rapid expansion of the production lines to 12.
The entire area of the acquired land is 100,000 sqm and allows for further development of the production facilities through the construction of new buildings, depending on market demand and in relation to the company’s ongoing development needs.
The finished products from the Turda facility – both prescription and non-prescription pharmaceuticals – are intended to serve mainly Romania and the European markets where the STADA Group operates.
“STADA is developing in Turda the first pharmaceutical factory built from scratch in Romania by an international company, thus laying a cornerstone in making Romania today an important player in the European pharmaceutical sector, while securing the supply chain in this strategic area. We chose Turda because it is located in the heart of a key region for the STADA Group. It is close to our warehouse in Timisoara, close to our production facilities in Serbia, as well as to our testing laboratory serving the entire STADA Group globally.” underlines Mihai Fugarevici, General Manager of STADA Romania.
“The Romanian Government equally supports both foreign and domestic investments in key areas that position Romania as an important player on the European map. It is part of our strategy to ensure a transparent and honest framework for all investments that ensure a development of the quality of life in our country and also create new jobs.” said Mr Ciprian Hojda, State Counsellor in the Romanian Government, Prime Minister’s Office.
“As a doctor and as Chairman of the Health Committee in the Senate, I am pleased that Romania is attracting the attention of healthcare companies, which are coming and investing here. In this way, on the one hand, a two-way transfer of know-how is ensured between the specialists of their research laboratories and our specialists, thus increasing the degree of specialisation of all, and on the other hand, it shortens the journey and access of Romanian patients to affordable and high-quality treatments,” adds Prof. Dr. Adrian Streinu Cercel, Senator in the Romanian Parliament.
The STADA factory in Turda will be built on a solid foundation of sustainability, using modern, state-of-the-art technology and a suite of energy-saving facilities such as photovoltaic solar panels, solar thermal system, and green roof to balance temperature fluctuations. The construction and operational phases will be coordinated by Veroljub Ljubinkovic, who will lead the project as plant manager.
The production facility is scheduled for completion in October 2024. The facility’s operation involves forming a team of 375 employees with a wealth of experience in the pharmaceutical industry, which will build on Cluj’s strong heritage in this field.